From 1 July 2023, Vaxelis® will be added to the National Immunisation Program (NIP).
Vaxelis® is a hexavalent (six-in-one) vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B (Hib).
Vaxelis® is registered for use from 6 weeks of age. It does not require reconstitution.
More information will be shared when it becomes available.